Filtros : "BIOFÍSICA" "Reino Unido" Removido: "FEBS Open Bio" Limpar

Filtros



Limitar por data


  • Fonte: Nature Communications. Unidade: IFSC

    Assuntos: ZIKA VÍRUS, VÍRUS, DENGUE, BIOFÍSICA

    Versão PublicadaAcesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      NI, Xiaomin et al. Combined crystallographic fragment screening and deep mutational scanning enable discovery of Zika virus NS2B-NS3 protease inhibitors. Nature Communications, v. 16, p. 8930-1-8930-13 + supplementary information, 2025Tradução . . Disponível em: https://doi.org/10.1038/s41467-025-63602-z. Acesso em: 06 nov. 2025.
    • APA

      Ni, X., Godoy, A. S. de, Dolci, I., Fernandes, R. S., & Oliva, G. (2025). Combined crystallographic fragment screening and deep mutational scanning enable discovery of Zika virus NS2B-NS3 protease inhibitors. Nature Communications, 16, 8930-1-8930-13 + supplementary information. doi:10.1038/s41467-025-63602-z
    • NLM

      Ni X, Godoy AS de, Dolci I, Fernandes RS, Oliva G. Combined crystallographic fragment screening and deep mutational scanning enable discovery of Zika virus NS2B-NS3 protease inhibitors [Internet]. Nature Communications. 2025 ; 16 8930-1-8930-13 + supplementary information.[citado 2025 nov. 06 ] Available from: https://doi.org/10.1038/s41467-025-63602-z
    • Vancouver

      Ni X, Godoy AS de, Dolci I, Fernandes RS, Oliva G. Combined crystallographic fragment screening and deep mutational scanning enable discovery of Zika virus NS2B-NS3 protease inhibitors [Internet]. Nature Communications. 2025 ; 16 8930-1-8930-13 + supplementary information.[citado 2025 nov. 06 ] Available from: https://doi.org/10.1038/s41467-025-63602-z
  • Fonte: ChemMedChem: chemistry enabling drug. Unidade: ICB

    Assuntos: MICROBIOLOGIA, FÁRMACOS, MEDICAMENTO, TRIAGEM, BIOFÍSICA

    Acesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      KIRKMAN, Tim et al. How to find a fragment: methods for screening and validation in fragment-based drug discovery. ChemMedChem: chemistry enabling drug, v. 19, n. 24, p. 14 , 2024Tradução . . Disponível em: https://doi.org/10.1002/cmdc.202400342. Acesso em: 06 nov. 2025.
    • APA

      Kirkman, T., Silva, C. dos S., Tosin, M., & Dias, M. V. B. (2024). How to find a fragment: methods for screening and validation in fragment-based drug discovery. ChemMedChem: chemistry enabling drug, 19( 24), 14 . doi:10.1002/cmdc.202400342
    • NLM

      Kirkman T, Silva C dos S, Tosin M, Dias MVB. How to find a fragment: methods for screening and validation in fragment-based drug discovery [Internet]. ChemMedChem: chemistry enabling drug. 2024 ; 19( 24): 14 .[citado 2025 nov. 06 ] Available from: https://doi.org/10.1002/cmdc.202400342
    • Vancouver

      Kirkman T, Silva C dos S, Tosin M, Dias MVB. How to find a fragment: methods for screening and validation in fragment-based drug discovery [Internet]. ChemMedChem: chemistry enabling drug. 2024 ; 19( 24): 14 .[citado 2025 nov. 06 ] Available from: https://doi.org/10.1002/cmdc.202400342

Biblioteca Digital de Produção Intelectual da Universidade de São Paulo     2012 - 2025